MUP is one of the most recent pharmaceutical firms in Egypt. In the scenic region near the city of Ismailia, MUPhas established a modern pharmaceutical manufacturing facility which incorporates many contemporary construction design features, raw materials handling, production concepts, and state-of-the-art manufacturing lines which rival the most modern American, European and Japanese counterparts. MUP adopts the Total Quality Management (TOM) concept and methodology in all departments and up-to-date Quality Assurance (QA) techniques, not only in all production processes, but also in all administrative and supporting departments.
MUP acquired the latest ISO 9001:2008 Certificate from the British Standards Institute (bsi), and recently upgraded the conventional plant to be certified to ISO, 14001, 18001 & 17025 by the end of year 2015 . MUP is proceeding in the new Cephalosporin and Penicillin Plants and all sets for the EMEA certification.
Today, MUP provides trusted generic, branded generic and specialty pharmaceutical products to more than 30 countries in Africa, the MENA region, and Western Europe and are aggressively building a leading position in providing international initiatives satisfying countries and communities that collaborate with us. MUP provides many products that cover several therapeutic areas, such as:
Gastroenterology, Dermatology, Gynecology, Andrology, Cardiovascular, Dentistry, Anti-Infectives, Vitamins and Tonics, Anti-Histaminics, Analgesics and Anti-Rheumatics, Endocrinology, Hepatology, Respiratory, Neurology.
Contact
Headquarters
MUP, Inc. 36 Dr . Mohammad Hassan El-Gamal St., 6th District-Nasr City- Cairo-A.R.E P.O.Box : 7010 Nasr City Kost No : 11768 Tel : (+20) 22709324 / 22709316 / 22709535 / 22726169 Fax : (+20) 22709315
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence…
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
Tabuk Pharmaceuticals, the largest private Saudi pharmaceutical company with commercial operations in 25 countries in middle east and 5 European countries with a portfolio of more than 250 products, chose…
Egypt can boast some of the most modern manufacturing sites in the Arab world. The CEO of Future Pharmaceutical Industries discusses the importance of promoting exports, the ambitious plans of…
Starting as a pharmacy chain, Hefny Pharma Group has developed into a group focused on manufacturing, importing and distributing pharmaceutical products to the Egyptian market, with an eye on the…
The chairman of Egypt’s largest holding company for pharmaceutical manufacturers, ACDIMA, shares his vision for how Egyptian manufacturers can enhance their competitiveness in the coming years, and extend their activities…
Marcyrl grew 40 percent and jumped from 15th to 9th place in the Egyptian market in 2014. With growth remaining strong, the board explains the keys to success for doing…
With a large and growing population, and significant domestic health needs, Lilly Egypt general manager Ozkan Ozdogan sees many opportunities for various stakeholders to serve patients, and is focusing on…
Servier Egypt’s recently arrived general manager shares his first impressions and assessments of the Egyptian business environment, and discusses the potential he sees for Servier Egypt to build upon its…
OrganoPharma’s founder and chairman Dr. Mowfak Sakr explains how he founded his company to try and provide the 40 million people in Egypt who lack healthcare insurance of any kind…
Phyto-Pharmaceuticals often offer better, more sustainable treatment solutions than synthetic pharmaceuticals, explains the Sekem group’s CEO Helmy Abouleish. Atos Pharma’s CEO Ashraf Mamdouh expands on the companies current plans for…
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence…
As the founder of Egypt’s leading commercial agent for advanced medical technologies, Mahmoud Bagneid has a simple goal for Egyptian healthcare; for all Egyptian’s to be aware that they should…